See All Slides - tctmd.com

Slides

Presentation TCT 2013

The Hybrid Approach IV: When to go Retrograde and to Select Septals

Presenter: Julian Strange

October 28, 2013

Presentation TCT 2013

How to Get Started

Presenter: Adhir Shroff

October 28, 2013

Presentation TCT 2013

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

30-Day Readmission Criteria: How to Adapt and Reduce Your Risk

Presenter: Bruce Samuels

October 28, 2013

Presentation TCT 2013

Not So Fast—Direct Carotid Access Flow Reversal Is Queen!

Presenter: Sumaira Macdonald

October 28, 2013

Presentation TCT 2013

Transradial Intervention in STEMI: How Long Can We Delay Door-to-Balloon Time?

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results(3)

Presenter: Karl-Heinz Kuck

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Joachim Schofer

October 28, 2013

Presentation TCT 2013

Selecting the Best Antiplatelet Strategy for ACS and Stable CAD

Presenter: Oscar Mendiz

October 28, 2013

Advertisement

Slides

The Hybrid Approach IV: When to go Retrograde and to Select Septals

How to Get Started

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

30-Day Readmission Criteria: How to Adapt and Reduce Your Risk

Not So Fast—Direct Carotid Access Flow Reversal Is Queen!

Transradial Intervention in STEMI: How Long Can We Delay Door-to-Balloon Time?

Technology Review and Clinical Results(3)

Do I Really Need Bioresorbable Scaffolds in the United States?

DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Selecting the Best Antiplatelet Strategy for ACS and Stable CAD

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content